Skip to main content
Top
Published in: Rheumatology International 5/2011

01-05-2011 | Original Article

Lag time between onset of symptoms and diagnosis in Venezuelan patients with rheumatoid arthritis

Authors: Elaudi Rodríguez-Polanco, Soham Al Snih, Yong-Fang Kuo, Alberto Millán, Martín A. Rodríguez

Published in: Rheumatology International | Issue 5/2011

Login to get access

Abstract

A retrospective study in a hospital-based sample of Venezuelan patients with rheumatoid arthritis was made to estimate the lag time between onset of symptoms, diagnosis, and initiation of DMARD treatment. Medical records and in-person interview of patients to fill in a questionnaire collecting information on demographics and initiation of symptoms, first consultation with any physician, time of diagnosis, and initiation of first disease-modifying anti-rheumatic drug were reviewed. We performed descriptive statistics and multivariable linear regression analysis. Mean lag time between symptom onset and diagnosis of rheumatoid arthritis was 40.5 months (range 1–424). Mean lag time between onset of symptoms and first consultation with a physician and between first consultation and diagnosis was 16.3 and 23.9 months, respectively. Mean lag time between onset of symptoms and initiation of DMARD treatment was 56.9 months. A definitive diagnosis of rheumatoid arthritis was done by a rheumatologist in 251 patients (92.3%). First consultation with an orthopedist or a primary care physician, first consultation in a public versus a private health center, and diagnosis before 2000 were associated with longer lag time between onset of symptoms and diagnosis. Venezuelan patients with rheumatoid arthritis had a marked delay from disease onset to diagnosis and initiation of first DMARD. First consultation with an orthopedist and consultation in a public versus a private health center were the variables with the strongest effect on lag time to diagnosis and to initiation of first DMARD.
Literature
1.
go back to reference Bjelle A, Mägi M (1981) Rheumatic disorders in primary care: study of two primary care centers and a review of previous Swedish reports on primary care Scand. J Rheumatol 10:331–341 Bjelle A, Mägi M (1981) Rheumatic disorders in primary care: study of two primary care centers and a review of previous Swedish reports on primary care Scand. J Rheumatol 10:331–341
2.
go back to reference Aletaha D, Eberl G, Nell VPK, Machold KP, Smolen JS (2002) Practical progress in realisation of early diagnosis and treatment in patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years. Ann Rheum Dis 61:630–634PubMedCrossRef Aletaha D, Eberl G, Nell VPK, Machold KP, Smolen JS (2002) Practical progress in realisation of early diagnosis and treatment in patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years. Ann Rheum Dis 61:630–634PubMedCrossRef
3.
go back to reference van der Heidi A, Jacobs JWG, Bijlsma JWJ et al (1996) The benefits of early treatment with “second-line” antirheumatic drugs: a randomised, controlled trial. Ann Intern Med 124:699–706 van der Heidi A, Jacobs JWG, Bijlsma JWJ et al (1996) The benefits of early treatment with “second-line” antirheumatic drugs: a randomised, controlled trial. Ann Intern Med 124:699–706
4.
go back to reference Egsmose C, Lund B, Borg G et al (1995) Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5-year follow-up of a prospective double blind placebo controlled study. J Rheumatol 22:2208–2213PubMed Egsmose C, Lund B, Borg G et al (1995) Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5-year follow-up of a prospective double blind placebo controlled study. J Rheumatol 22:2208–2213PubMed
5.
go back to reference Mottonen T, Hannonen P, Leirisalo-Repo M et al (1999) Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomized trial. FIN-RACO trial group. Lancet 353:1568–1573PubMedCrossRef Mottonen T, Hannonen P, Leirisalo-Repo M et al (1999) Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomized trial. FIN-RACO trial group. Lancet 353:1568–1573PubMedCrossRef
6.
go back to reference Irvine S, Munro R, Porter D (1999) Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice. Ann Rheum Dis 58:510–513PubMedCrossRef Irvine S, Munro R, Porter D (1999) Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice. Ann Rheum Dis 58:510–513PubMedCrossRef
7.
go back to reference Boers M (2003) Understanding the window of opportunity concept in early rheumatoid arthritis. Arthritis Rheum 48:1771–1774PubMedCrossRef Boers M (2003) Understanding the window of opportunity concept in early rheumatoid arthritis. Arthritis Rheum 48:1771–1774PubMedCrossRef
8.
go back to reference van der Heijde DMFM (1995) Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 34(Suppl 2):74–78PubMed van der Heijde DMFM (1995) Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 34(Suppl 2):74–78PubMed
9.
go back to reference Bykerk VP, Baron M, Boire G, Haraoui B, Khraishi M, LeClercq S, Pope JE, Keystone EC (2004) Canadian consensus statement on early optimal therapy of rheumatoid arthritis. J Can Rheumatol Assoc (Autumn) 11-3 Bykerk VP, Baron M, Boire G, Haraoui B, Khraishi M, LeClercq S, Pope JE, Keystone EC (2004) Canadian consensus statement on early optimal therapy of rheumatoid arthritis. J Can Rheumatol Assoc (Autumn) 11-3
10.
go back to reference Fuchs HA, Kaye JJ, Kallahan LF et al (1989) Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 16:585–591PubMed Fuchs HA, Kaye JJ, Kallahan LF et al (1989) Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 16:585–591PubMed
11.
go back to reference Chan KA, Nelson DT, Walter AM (1994) The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis Rheum 37:814–820PubMedCrossRef Chan KA, Nelson DT, Walter AM (1994) The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis Rheum 37:814–820PubMedCrossRef
12.
go back to reference Gray M, Nuki G (2001) Audit of delay between symptom onset and commencement of disease modifying anti-rheumatic drugs (DMARDs) in patients with newly diagnosed rheumatoid arthritis referred to a hospital rheumatology unit. Rheumatology 40(Suppl. 1):60 Gray M, Nuki G (2001) Audit of delay between symptom onset and commencement of disease modifying anti-rheumatic drugs (DMARDs) in patients with newly diagnosed rheumatoid arthritis referred to a hospital rheumatology unit. Rheumatology 40(Suppl. 1):60
13.
go back to reference Bashda H, Kong KO, Tak PP (2007) Rheumatoid arthritis in Dubai: delayed diagnosis and low usage of disease modifying antirheumatic drugs. Ann Rheum Dis 66:835CrossRef Bashda H, Kong KO, Tak PP (2007) Rheumatoid arthritis in Dubai: delayed diagnosis and low usage of disease modifying antirheumatic drugs. Ann Rheum Dis 66:835CrossRef
14.
go back to reference Palm O, Purinszky E (2005) Women with early rheumatoid arthritis are referred later than men. Ann Rheum Dis 64:1227–1228PubMedCrossRef Palm O, Purinszky E (2005) Women with early rheumatoid arthritis are referred later than men. Ann Rheum Dis 64:1227–1228PubMedCrossRef
15.
go back to reference Xibillié-Friedman D, Mondragón-Flores V, Horcasitas de la Rosa C (2006) Criteria used by primary care physicians for the diagnosis and the referral to a rheumatologist of patients with rheumatoid arthritis. Reumatol Clin 2:235–238CrossRef Xibillié-Friedman D, Mondragón-Flores V, Horcasitas de la Rosa C (2006) Criteria used by primary care physicians for the diagnosis and the referral to a rheumatologist of patients with rheumatoid arthritis. Reumatol Clin 2:235–238CrossRef
16.
go back to reference Palleiro D (2006) Diagnostic delay in rheumatoid arthritis. J Clin Rheumatol 12:S41CrossRef Palleiro D (2006) Diagnostic delay in rheumatoid arthritis. J Clin Rheumatol 12:S41CrossRef
17.
go back to reference Massardo L, Aguirre V, García ME, Cervilla V, Nicovani S, González A et al (1995) Clinical expression of rheumatoid arthritis in Chilean patients. Semin Arthritis Rheum 25:203–213PubMedCrossRef Massardo L, Aguirre V, García ME, Cervilla V, Nicovani S, González A et al (1995) Clinical expression of rheumatoid arthritis in Chilean patients. Semin Arthritis Rheum 25:203–213PubMedCrossRef
18.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef
19.
go back to reference Graffar M (1956) Une methode de classification sociales d′chantillons de populations. Courrier 6:445–459 Graffar M (1956) Une methode de classification sociales d′chantillons de populations. Courrier 6:445–459
20.
go back to reference Mendez-Castellanos H, Mendez MC (1986) Estratificación social y biología humana: Método Graffar modificado. Arch Puer Ped 49:93–104 Mendez-Castellanos H, Mendez MC (1986) Estratificación social y biología humana: Método Graffar modificado. Arch Puer Ped 49:93–104
21.
go back to reference Feldman DE, Bertnasky S, Haggerty J, Leffondré K, Tousignant P, Roy Y et al (2007) Delay in consultation with specialists for persons with suspected new-onset rheumatoid arthritis: a population-based study. Arthritis Rheum (Arthritis Care Res) 57:1419–1425CrossRef Feldman DE, Bertnasky S, Haggerty J, Leffondré K, Tousignant P, Roy Y et al (2007) Delay in consultation with specialists for persons with suspected new-onset rheumatoid arthritis: a population-based study. Arthritis Rheum (Arthritis Care Res) 57:1419–1425CrossRef
22.
go back to reference Van der Horst-Bruinsma IE, Speyer I, Visser H, Breedveld FC, Hazes JMW (1998) Diagnosis and course of early-onset arthritis: Results of a special early arthritis clinic compared to routine patient care. Br J Rheumatol 37:1084–1088PubMedCrossRef Van der Horst-Bruinsma IE, Speyer I, Visser H, Breedveld FC, Hazes JMW (1998) Diagnosis and course of early-onset arthritis: Results of a special early arthritis clinic compared to routine patient care. Br J Rheumatol 37:1084–1088PubMedCrossRef
23.
go back to reference Latin American Rheumatology Associations of the Pan-American League of Associations (PANLAR), Grupo Latinoamericano de Estudio de Artritis Reumatoide (GLADAR) (2006) Rheumatology 45:ii7–ii22 Latin American Rheumatology Associations of the Pan-American League of Associations (PANLAR), Grupo Latinoamericano de Estudio de Artritis Reumatoide (GLADAR) (2006) Rheumatology 45:ii7–ii22
24.
go back to reference Criswell LA, Such CL, Yelin EH (1997) Differences in the use of second-line agents and prednisone for treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists. J Rheumatol 24:2283–2290PubMed Criswell LA, Such CL, Yelin EH (1997) Differences in the use of second-line agents and prednisone for treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists. J Rheumatol 24:2283–2290PubMed
25.
go back to reference Hooker RS, Brown JB (1990) Rheumatology referral patterns. HMO Practice 4:61–65PubMed Hooker RS, Brown JB (1990) Rheumatology referral patterns. HMO Practice 4:61–65PubMed
26.
go back to reference Lacaille D, Anis AH, Guh DP, Esdaile JM (2005) Gaps for care in rheumatoid arthritis: a population study. Arthritis Rheum (Arthritis Care Res) 53:241–248CrossRef Lacaille D, Anis AH, Guh DP, Esdaile JM (2005) Gaps for care in rheumatoid arthritis: a population study. Arthritis Rheum (Arthritis Care Res) 53:241–248CrossRef
27.
go back to reference Gámez-Nava JI, González-López L, Davies P, Suárez-Almazor ME (1998) Referral and diagnosis of common rheumatic diseases by primary care physicians. Rheumatology 37:1215–1219CrossRef Gámez-Nava JI, González-López L, Davies P, Suárez-Almazor ME (1998) Referral and diagnosis of common rheumatic diseases by primary care physicians. Rheumatology 37:1215–1219CrossRef
28.
go back to reference Sverdup B, Allebeck P, Allender E (1993) Tentative diagnoses among referrals versus diagnosis established at the department of rheumatology. Scand J Rheumatol 12:377–378CrossRef Sverdup B, Allebeck P, Allender E (1993) Tentative diagnoses among referrals versus diagnosis established at the department of rheumatology. Scand J Rheumatol 12:377–378CrossRef
29.
go back to reference Bolumar S, Ruiz M, Hernandez I, Pascual E (1994) Reliability of the diagnosis of the rheumatic diseases at the primary health care level. J Rheumatol 21:2344–2348PubMed Bolumar S, Ruiz M, Hernandez I, Pascual E (1994) Reliability of the diagnosis of the rheumatic diseases at the primary health care level. J Rheumatol 21:2344–2348PubMed
30.
go back to reference Hernández-García C, Vargas E, Abásolo L, Lajas C, Bellajdell B, Morado IC et al (2000) Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis. J Rheumatol 27:2323–2328PubMed Hernández-García C, Vargas E, Abásolo L, Lajas C, Bellajdell B, Morado IC et al (2000) Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis. J Rheumatol 27:2323–2328PubMed
31.
go back to reference Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS (2002) Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 61:290–297PubMedCrossRef Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS (2002) Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 61:290–297PubMedCrossRef
32.
go back to reference Nell VP, Machold KP, Eberl G, Stam TA, Uffman M, Smolen JS (2004) Benefit of very early referral and very early therapy with disease modifying antirheumatic drugs in patients with early rheumatoid arthritis. Rheumatology 43:906–914PubMedCrossRef Nell VP, Machold KP, Eberl G, Stam TA, Uffman M, Smolen JS (2004) Benefit of very early referral and very early therapy with disease modifying antirheumatic drugs in patients with early rheumatoid arthritis. Rheumatology 43:906–914PubMedCrossRef
33.
go back to reference American College of Rheumatology (2002) Guidelines for the management of rheumatoid arthritis 2002 update. Arthritis Rheum 46:328–346CrossRef American College of Rheumatology (2002) Guidelines for the management of rheumatoid arthritis 2002 update. Arthritis Rheum 46:328–346CrossRef
Metadata
Title
Lag time between onset of symptoms and diagnosis in Venezuelan patients with rheumatoid arthritis
Authors
Elaudi Rodríguez-Polanco
Soham Al Snih
Yong-Fang Kuo
Alberto Millán
Martín A. Rodríguez
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 5/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1358-9

Other articles of this Issue 5/2011

Rheumatology International 5/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.